Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Abattis Bioceuticals Corp ATTBF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.


GREY:ATTBF - Post by User

Abattis Bioceuticals Corp
Bullboard Posts
User Avatar Image
(113)
•••
Comment by Kornootoon Aug 08, 2018 7:31am
145 Views
Post# 28425651

RE:Abattis Bioceuticals Announces Share Buy Back Program !!!

RE:Abattis Bioceuticals Announces Share Buy Back Program !!!

 

"The management team at Abattis believes that, compared to its market peers, the Company's shares are undervalued," said Rob Abenante, Abattis President and CEO. "We are proud of the foundation we have built through our recent acquisitions and joint ventures and believe we are in a great financial position thanks to several over-subscribed capital raises and dispositions. With the legalization of recreational marijuana anticipated for October of this year, we believe we will be in an excellent position to generate revenues and be a leader in the cannabis space. We also believe our shares represent a great value at current prices and are willing to bet on ourselves as we head into this exciting quarter," added Mr. Abenante.


Read more at https://www.stockhouse.com/companies/bullboard?symbol=c.att&postid=28423968#M3jcJgmihPHRyjHE.99
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities